Sign in Subscribe
Cancer

Activation of WD Repeat and High-Mobility Group Box DNA Binding Protein 1 in Pulmonary and Esophageal Carcinogenesis

Strategic Insights

— 1 min read

Researchers at the University of Tokyo's Institute of Medical Science have made a significant discovery regarding the role of WD repeat and high-mobility group box DNA binding protein 1 (WDHD1) in lung and esophageal cancer. The study, published in Clinical Cancer Research, aimed to identify novel biomarkers and therapeutic targets for these cancers. WDHD1 was found to be overexpressed in a large proportion of lung and esophageal carcinomas, and its expression was associated with a poor prognosis for patients with non-small cell lung cancer and esophageal squamous cell carcinoma.

Key Takeaways:

  • WDHD1 expression is associated with poor prognosis in non-small cell lung cancer and esophageal squamous cell carcinoma.
  • WDHD1 is an independent prognostic factor for esophageal squamous cell carcinoma.
  • Suppression of WDHD1 expression with small interfering RNAs effectively suppresses lung and esophageal cancer cell growth.
  • Induction of exogenous WDHD1 expression promotes the growth of mammalian cells.
  • AKT1 kinase phosphorylates and stabilizes the WDHD1 protein in cancer cells, making WDHD1 a potential therapeutic target.
  • WDHD1 is likely to play a significant role in lung and esophageal carcinogenesis as a cell cycle regulator and downstream molecule in the phosphoinositide 3-kinase/AKT pathway.

Statistics:

  • 27,648 genes or expressed sequence tags were screened using a cDNA microarray.
  • 267 archival non-small cell lung cancers and 283 esophageal squamous cell carcinomas were analyzed using tumor tissue microarrays.
  • Positive WDHD1 immunostaining was associated with poor prognosis in non-small cell lung cancer (p=0.0403) and esophageal squamous cell carcinoma (p=0.0426).
  • Multivariate analysis indicated WDHD1 to be an independent prognostic factor for esophageal squamous cell carcinoma (p=0.0104).

Sources:

  • N. Sato, et al. "Activation of WD repeat and high-mobility group box DNA binding protein 1 in pulmonary and esophageal carcinogenesis." Clinical Cancer Research, 2010;16(1):226-39.
  • Cancer Gene Therapy Week editors. "New research 'activation of WD repeat and high-mobility group box DNA binding protein 1 in pulmonary and esophageal carcinogenesis,'" Cancer Gene Therapy Week, 2010.

Read more